4 employees
Asalyxa Bio is committed to developing neutrophil targeting treatments for diseases with a high unmet medical need.
2020
$2M
from 4 investors over 4 rounds
Asalyxa Bio raised undisclosed on July 26, 2021
Investors: Michigan Rise
Asalyxa Bio raised $2M on February 23, 2021
Investors: Woodward Angels, Translational Research Institute and Michigan Rise